Myopericarditis After COVID-19 Booster Dose Vaccination.
作者信息
Sharff Katie A, Dancoes David M, Longueil Jodi L, Lewis Paul F, Johnson Eric S
机构信息
Department of Infectious Diseases, Kaiser Permanente Northwest, Portland, Oregon.
Department of Analytics, Kaiser Permanente Northwest, Portland, Oregon.
出版信息
Am J Cardiol. 2022 Jun 1;172:165-166. doi: 10.1016/j.amjcard.2022.02.039. Epub 2022 Mar 26.
Abstract
摘要
相似文献
1
Myopericarditis After COVID-19 Booster Dose Vaccination.新冠病毒加强针接种后的心肌心包炎
Am J Cardiol. 2022 Jun 1;172:165-166. doi: 10.1016/j.amjcard.2022.02.039. Epub 2022 Mar 26.
2
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗接种与心肌炎或心肌心包炎：基于人群的队列研究
BMJ. 2021 Dec 16;375:e068665. doi: 10.1136/bmj-2021-068665.
3
Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.12至18岁青少年接种2019冠状病毒病信使核糖核酸疫苗后的心肌心包炎
J Pediatr. 2021 Nov;238:26-32.e1. doi: 10.1016/j.jpeds.2021.07.044. Epub 2021 Jul 30.
4
Myopericarditis in a Young Adult Secondary to COVID-19 Vaccination.COVID-19 疫苗接种后导致青年人心肌心包炎。
Methodist Debakey Cardiovasc J. 2021 Sep 22;17(3):13-17. doi: 10.14797/mdcvj.847. eCollection 2021.
5
Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.2019冠状病毒病mRNA疫苗接种后确诊的急性心肌炎
Circ J. 2022 Mar 25;86(4):724. doi: 10.1253/circj.CJ-21-0840. Epub 2021 Dec 4.
6
Pneumonitis and Myopericarditis After Booster COVID-19 mRNA Vaccination.新冠病毒疾病2019（COVID-19）加强针mRNA疫苗接种后的肺炎和心肌心包炎
Am J Ther. 2023;30(6):e555-e559. doi: 10.1097/MJT.0000000000001492. Epub 2022 Mar 25.
7
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.青少年接种辉瑞信使核糖核酸冠状病毒病疫苗后的心肌炎。
J Pediatr. 2021 Nov;238:317-320. doi: 10.1016/j.jpeds.2021.06.083. Epub 2021 Jul 3.
8
Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).辉瑞-BioNTech COVID-19 疫苗接种后 28 天（每 10 万人中有 4.2 例）与心肌炎或心包炎相关。
Ann Intern Med. 2022 May;175(5):JC58. doi: 10.7326/J22-0021. Epub 2022 May 3.
9
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
10
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.mRNA COVID-19 疫苗接种后发生急性心肌炎的患者。
JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi: 10.1001/jamacardio.2021.2828.
引用本文的文献
1
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.在有和没有先前 SARS-CoV-2 感染的人群中，COVID-19 mRNA 疫苗加强针接种后和 COVID-19 后心肌炎和心包炎的风险：在英国的一项自身对照病例系列分析。
PLoS Med. 2023 Jun 7;20(6):e1004245. doi: 10.1371/journal.pmed.1004245. eCollection 2023 Jun.
2
COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities.为年轻人接种 COVID-19 疫苗加强针：对大学强制接种政策的风险收益评估和伦理分析。
J Med Ethics. 2024 Jan 23;50(2):126-138. doi: 10.1136/jme-2022-108449.
3
Hospitalised Myocarditis and Pericarditis Cases in Germany Indicate a Higher Post-Vaccination Risk for Young People Mainly after COVID-19 Vaccination.德国住院治疗的心肌炎和心包炎病例表明，年轻人在接种疫苗后，尤其是在接种新冠疫苗后，出现不良反应的风险更高。
J Clin Med. 2022 Oct 14;11(20):6073. doi: 10.3390/jcm11206073.
4
Acute Myopericarditis After the Third Vaccination of BNT162b2 in a Middle-Aged Man.一名中年男性接种第三剂BNT162b2疫苗后发生急性心肌心包炎
Cureus. 2022 Sep 6;14(9):e28857. doi: 10.7759/cureus.28857. eCollection 2022 Sep.
5
Myocarditis Following COVID-19 Vaccination: Cardiac Imaging Findings in 118 Studies.接种 COVID-19 疫苗后的心肌炎：118 项研究中的心脏影像学表现。
Tomography. 2022 Jul 30;8(4):1959-1973. doi: 10.3390/tomography8040164.
6
Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis.全球 COVID-19 疫苗接种后心肌炎报告：系统评价和荟萃分析。
Diabetes Metab Syndr. 2022 Jun;16(6):102513. doi: 10.1016/j.dsx.2022.102513. Epub 2022 May 27.
本文引用的文献
1
Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.在大型综合医疗体系中，COVID-19 mRNA 疫苗接种后的心肌炎风险：两种方法的完整性和及时性比较。
Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):921-925. doi: 10.1002/pds.5439. Epub 2022 Apr 16.
2
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
3
Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and Prevention.美国疾病控制与预防中心监测流感疫苗上市后安全性的监测系统及方法
Expert Opin Drug Saf. 2016 Sep;15(9):1175-83. doi: 10.1080/14740338.2016.1194823. Epub 2016 Jun 16.
Zotero 插件